Shannon Tarr

Shannon Tarr is an experienced clinical operations professional currently serving as Associate Director at bluebird bio, specializing in Real World Evidence Study Management for gene therapy post-marketing registry operations since October 2022. Previous roles include Senior Clinical Trial Manager at Ultragenyx Pharmaceutical Inc., where responsibilities included managing a global phase III study and an expanded access program for pediatric rare diseases, and Manager of Clinical Operations at Lucid Diagnostics, overseeing an esophageal cancer screening study. Earlier experience includes positions as Senior Regional Site Manager at Planet Pharma, Clinical Trial Manager at ICON plc, and Senior Site Manager at ReSearch Pharmaceutical Services, with a focus on oncology trials. Shannon's career commenced as a Research Coordinator at Fairview Hospital/Cleveland Clinic, following an educational background that includes a Master's degree in Biology from Cleveland State University and a Bachelor's degree in Biology from John Carroll University.